--- the subscriber area has no ads ---
MicroVision, Resonant announcements and more -3
MicroVision has announced that it expects fourth quarter revenue to come in between $2.4 and $2.7M, with full year revenue at $10.7-11M. Both of these figures miss analyst estimates by over well over $3M. The miss is primarily due to this customer requesting a deferment of parts shipments until the first half of 2018.
Resonant has also disclosed its foundry partners to date, documenting that it is working with companies based in Korea, Japan, Taiwan and China. It's a good start, but the rush of press releases makes me more worried about impending dilution, not less. Investors have tolerated that so far, though, and I do see abundant evidence supporting success for the company's business model.
More broadly, I've seen chatter about the market rotating out of
income and towards growth. That might hold up for most or all of
2018, but it does not apply to companies like these, which will
have to raise capital at higher rates. Longer term, I still don't
see the economy and debt loads as sustainable. Ultimately, all
stocks are about (future) cash flow, and that's what I'm investing
in with stocks like BGCP, CVA, and CTL, each of which are each continuing
out their respective businesses.